- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 12.15M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $8.95M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $9.21M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1.77M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $2.2M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.79M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $2.06M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $13.35M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $11.94M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $31.96M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $31.73M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $10.92M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $9.71M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $34.09M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $34.11M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 9.23M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $74.22K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.55M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $8.98M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $8.99M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.08 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$701.46K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$601.75K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $6.05M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $9.84M |
| Revenue | Q1 2025 · Mar 31, 2024 | $15.89M |